Filing Details
- Accession Number:
- 0001104659-15-073216
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-10-27 21:47:15
- Reporting Period:
- 2015-10-23
- Filing Date:
- 2015-10-27
- Accepted Time:
- 2015-10-27 21:47:15
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1428522 | Radius Health Inc. | RDUS | Pharmaceutical Preparations (2834) | 800145732 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1521111 | Gary Hattersley | C/O Radius Health, Inc. 950 Winter St. Waltham MA 02145 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-10-23 | 874 | $3.42 | 874 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2015-10-23 | 10,428 | $2.05 | 10,428 | No | 4 | M | Direct | |
Common Stock | Disposition | 2015-10-23 | 11,302 | $65.00 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2015-10-23 | 874 | $0.00 | 874 | $3.42 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2015-10-23 | 10,428 | $0.00 | 10,428 | $2.05 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2009-12-31 | 2016-02-15 | No | 4 | M | Direct |
0 | 2011-04-01 | 2017-07-12 | No | 4 | M | Direct |
Footnotes
- The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 10, 2015.